MorphoSys AG to Update Financial Guidance for 2021 and Reduce Financial Liabilities
Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No 596/2014PLANEGG/MUNICH, GERMANY / ACCESSWIRE...
Month: July 2021
Reverse the Silence Campaign Casts a National Spotlight on Overdose Risks Associated with Opioid Use
Reverse the Silence_Darren Waller Video Production: Behind the Scenes Reverse the Silence_Darren Waller_Field Shot Video Production Behind the Scenes Reverse...
Stereotaxis Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D.
ST. LOUIS, July 26, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the...
Gracell Biotechnologies to Participate in Fireside Chat at the BTIG Virtual Biotechnology Conference
SUZHOU, China and PALO ALTO, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global...
Harrow Health to Announce Second Quarter 2021 Financial Results on August 10, 2021
NASHVILLE, Tenn., July 26, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced that...
Made of Millions Bolsters Made Academy Leadership Team with Five New Board Advisors
Pamela Lasner of Verizon Media, Simon Fenwick of 4A’s, Kay Nikiforova of Violet, Dr. Neha Chaudhary, Dr. Brittany Linton Join Made...
Editas Medicine Names Bruce E. Eaton, Ph.D., as Executive Vice President and Chief Business Officer
Bruce E. Eaton Editas Medicine announced Bruce E. Eaton, Ph.D., has been promoted to Executive Vice President and Chief Business...
Eyenuk AI Technology Selected for Diabetic Eye Testing in Vietnam Supported by The Fred Hollows Foundation
LOS ANGELES, July 26, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company...
NeuroMetrix Announces Peer-Reviewed Publication of a Randomized Controlled Trial of its Wearable Neurostimulation Technology for Treatment of Fibromyalgia
WOBURN, Mass., July 26, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced a publication titled “Effects of Wearable...
Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association International Conference 2021
Late-breaking PRX012 poster highlights significant ex vivo clearance of both pyroglutamate-modified and -unmodified Aβ plaque from AD brain at concentrations...
Generex Biotechnology Corporation Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical, has gained approval for the use of Excellagen® Wound Conforming Matrix from The Malaysian Ministry of Health, its country’s equivalent to the U.S. FDA
MIRAMAR, Fla., July 26, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) subsidiary Olaregen Therapeutix announced in May that...
Allied Corp Commends the Colombian Authorities for Approving the Export of Dried Cannabis Flower From Colombia
KELOWNA, British Columbia, July 26, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical...
LifeMD to Release Second Quarter 2021 Financial Results on Thursday, August 12, 2021
Hosted conference call to begin at 4:30 p.m. ETNEW YORK, July 26, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”)...
Odyssey Group International, Inc. Provides Notice of Annual Meeting of Stockholders
IRVINE, CA, July 26, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY) ("ODYY" or "the Company"), Odyssey Group International,...
INmune Bio, Inc. Announces Design of Upcoming Phase 2 Alzheimer’s Disease Clinical Trial and New Phase 1b AD Biomarker Data
Phase 2 study of XProTM will be a six-month, blinded, randomized, placebo-controlled trial in 168 patients with mild Alzheimer’s disease...
Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021
Management to host conference callWALTHAM, Mass., July 26, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical...
Cassava Sciences Announces Positive Data with SavaDx from a Randomized Controlled Phase 2b Study of Simufilam
SavaDx Detected Significant Changes in Plasma Levels of Altered Filamin A in Patients with Alzheimer’s Disease Before and After Simufilam...
Skye Bioscience Appoints Biotech Executive Praveen Tyle, Ph.D. to Board of Directors
SAN DIEGO, CA, July 26, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical...
Genetic Technologies Rapidly Accelerating Commercialization Plans
MELBOURNE, Australia, July 26, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics...
BiomX Inc. Announces $15 Million Registered Direct Offering
NESS ZIONA, Israel, July 26, 2021 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage...